These guidelines represent a breakthrough for younger women with breast cancer. In a clear and concise format, Level I evidence is presented about enhanced survival benefit of chemotherapy and of hormone therapy and additional evidence is presented outlining reduced local occurrence using boost radiotherapy
Notes
"Approved by the NHMRC on 27 November 2003"
Bibliography
Bibliography: (page 75 - 97)
Notes
Also available in an electronic version via the Internet at: http://www.nbcc.org.au/resources/index.html